- This event has passed.
Science Headlines: COVID-19 Vaccines- Progress Toward Prevention
September 1, 7:00 pm - 8:00 pm
With well over 22 million cases and 700,000 deaths globally, the world desperately awaits a vaccine that can finally put an end to the COVID-19 pandemic. Over 100 vaccines are currently in development, but one of the most promising is AZD1222, developed by researchers at Oxford University and AstraZeneca. This vaccine, which relies on genetically engineered virus, moved into Phase 3 clinical trials in August. At least 30,000 people will be recruited to participate in the trials nationwide, and researchers in the Kansas City region have been selected to lead the local effort. Dr. Barbara Pahud, infectious disease specialist at Children’s Mercy Hospital is co-primary investigator alongside KU Medical Center’s Dr. Mario Castro, for this local study. Join us for a rare and valuable opportunity to hear from Dr. Pahud on how far we’ve come and how far we have to go toward a vaccine to end the pandemic.
Dr. Barbara Pahud is an infectious disease specialist and Associate Professor of Pediatrics at University of Missouri- Kansas City and Children’s Mercy Hospital, where she also serves as Associate Director of the NIH’s Vaccine Treatment and Evaluation Unit. Dr. Pahud is co-primary investigator alongside Dr. Mario Castro of the Phase 3 clinical trials of the COVID-19 vaccine AZD1222. She received her medical degree from La Salle University in Mexico City, Mexico and holds a Master of Public Health degree from Columbia University in New York. She completed her residency in pediatrics at Maimonides Medical Center in Brooklyn, New York and has completed fellowships at University of California, San Francisco and the Centers for Disease Control in collaboration with Stanford University Medical Center.
Accessing the program
This free, online program will take place via Zoom. Registration is currently open and will remain open until the event has ended. After you register you will receive an email with a link to join the session. To help us better serve our audiences, we have included some demographic questions in the registration form. Your response to these questions is voluntary but appreciated. Thank you!
The Linda Hall Library encourages people of all backgrounds and abilities to participate in our public programs. Closed captioning is provided. If you require additional reasonable accommodations in order to participate, please contact firstname.lastname@example.org or call 816.926.8753 at least 24 hours in advance of the event.
Once you register for this event, you will receive email communications from the Linda Hall Library and the Linda Hall Library Foundation. You may choose to opt out of these communications at any time. Your contact information will not be sold or provided to any third parties.
The program will also be livestreamed on the Library’s Facebook page.
This program is funded by the Ewing Marion Kauffman Foundation. Its content is solely the responsibility of the Linda Hall Library.
Further reading at the Linda Hall Library
- Allen, Arthur Vaccine : the controversial story of medicine’s greatest lifesaver . New York : W.W. Norton, 2007.
- Hefferon, Kathleen L. Biopharmaceuticals in plants : toward the next century of medicine. Boca Raton : CRC Press, 2010.
- Kluger, Jeffrey Splendid solution : Jonas Salk and the conquest of polio New York : G.P. Putnam’s Sons, 2004.
- Rodriguez, Ana Maria Edward Jenner : conqueror of smallpox Berkeley Heights, NJ : Enslow Publishers, 2006.